1. Home
  2. News
  3. NATCO Pharma Limited
  4. Press Release Jan 20 2022
More NATCO Pharma Limited news
NATCO Pharma LimitedNSE: NATCOPHARM

Press Release Jan 20 2022

Jan 20, 2022 at 3:19 PM EST · Issued by NATCO Pharma Limited

Filed with NSE · Jan 20, 2022 at 3:19 PM EST · 2 pages · English

On 6ix: 6ix.com/news/press-release-jan-20-2022-15

Watch NATCO Pharma's latest callNATCO Pharma (NSE:NATCOPHARM) Q2 2027 Earnings Call · Replay · Nov 13↗

NATCO Pharma Limited on 6ix

Earlier from NATCO Pharma

  • Press Release Jan 07 2022Jan 7, 2022
  • Press Release Jan 01 2022Jan 1, 2022
  • NATCO Pharma receives approval for Molnupiravir Capsules 200 mg for the treatment of Covid-19 in IndiaDec 29, 2021
  • Press Release Dec 28 2021Dec 28, 2021
  • Press Release Nov 18 2021Nov 18, 2021

Later from NATCO Pharma

  • NATCO announces License Agreement with the Medicines Patent PoolJan 21, 2022
  • Press Release Mar 07 2022Mar 7, 2022
  • NATCO Announces Launch of the First Generic Version of Revlimid (Lenalidomide capsules), in the U.S. marketMar 8, 2022
  • NATCO records INR 2043.8 Crore consolidated revenue and INR 170.0 Crore of profit, after tax, for the year ended March 31' 2022May 31, 2022
  • Press Release Jun 01 2022Jun 1, 2022
All NATCO Pharma news releases↗

Follow NATCO Pharma into a list and get an email when it puts out news.

Follow NATCO Pharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer